Joseph Hamer
Bpl-003 Ip Lead, European and Uk Patent Attorney @Ataibeckley
Signup · Get unlimited contacts
WORK HISTORY
Bpl-003 Ip Lead, European and Uk Patent Attorney @Ataibeckley
Reporting to the Chief Legal and Business Officer. AtaiBeckley ($ATAI) is a clinical-stage biopharmaceutical company created in November 2025 through the merger of atai Life Sciences and Beckley Psytech. The companies lead asset is the phase 3 ready BPL-003 (mebufotenin benzoate) which has received Breakthrough Therapy designation from the FDA for treatment-resistant depression. BPL-003 was originally developed by Beckley Psytech.
EDUCATION
Brunel University of London
Intellectual Property Law
University of Bath
Master’s Degree, Pharmacy
SKILLS
ABOUT JOSEPH HAMER
Passionate about IP and medicines innovation.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.